article Related Topics:
Ticlopidine
 

Ticlopidine (Ticlid) is an antiplatelet drug in the thienopyridine family. Like clopidogrel, it is an adenosine diphosphate (ADP) receptor inhibitor. It is used in patients in whom aspirin is not tolerated, or in whom dual antiplatelet therapy is desirable. Because it has been reported to increase the risk of thrombotic thrombocytopenic purpura (TTP) and neutropenia, its use has largely been supplanted by the newer drug, clopidogrel, which is felt to have a much lower hematologic risk. The usual dose is 250mg twice daily by the oral route.

Pregnancy Category: C

Action


  • Inihibits platelet aggregation by altering the function of platelet membranes.
  • Prolongs bleeding time.
  • Decreased incidence of stroke in high-risk patients.

Pharmacokinetic


Absorption: >80% absorbed after oral administration.
Distribution: Unknown
Protein Binding: 98%
Metabolism and Excretion: Extensively metabolized by the liver; minimal excretion of unchanged drug by the kidneys.
Half-life: Single dose - 12.6hr; Multiple Dosing - 4-5 days.

Contraindications


Precautions


Adverse Reactions and Side Effects


Route and Dosage


  • Adults: 400 mg/day taken with 8oz of plain water only, for 3 months.

ADP receptor inhibitors

Ticlopidina | Ticlopidina | 噻氯匹定

 

This article is licensed under the GNU Free Documentation License. It uses material from the "Ticlopidine".

Home Pageartsbusinesscomputersgameshealthhospitalshomekids & teensnewsphysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld